PlantEXT IBD formulation

Currently, our patent is pending on this unique, clinically tested formulation for inflammatory bowel disease. In a human biopsy study, our formulation showed more than 2x the reduction in inflammation, compared to corticosteroid treatment. This product will be used prophylactically to prevent/reduce inflammation and maintain remission.

Please note: product name is for illustration purposes only.